BioSpace - Financial Content

Symbol 'TARO' could not be found. Search For:

Tue, Dec 12, 2006
	Taro Shares to be Delisted From Nasdaq Company Shares Expected to Trade On Pink Sheets - GlobeNewswire
Thu, Nov 16, 2006
	Taro Receives Extension of Time from Nasdaq Panel for Filing of 2005 Form 20-F - Business Wire
Mon, Nov 13, 2006
	Taro Receives Marketing Authorization in UK for Etopan XL Tablets 600 mg, Etodolac - Business Wire
Wed, Nov 08, 2006
	Taro Receives ANDA Approval For Meloxicam Tablets, 7.5 mg and 15 mg, Generic Equivalent to Mobic Company Also Receives Tentative ANDA Approval for Cetirizine Syrup, Generic Equivalent to Zyrtec - GlobeNewswire
Mon, Oct 30, 2006
	Taro Receives Investigation Report - Business Wire
More Press Releases

Mon, Dec 11, 2006
	Taro May Be Acquired Ofer Hi-Tech is in negotiations to purchase Taro Pharmaceutical Industries Ltd. (TARO) sending the stock price up $1.53 to close at $12.65. - Market News
More News

11/17/05		Q3 2005 Earnings Archive for TARO
11/09/05		Q3 2005 Earnings Archive for TARO
07/28/05		Q2 2005 Earnings Archive for TARO
06/13/05		Special Conference Taro Pharmaceutical Industries at Morgan Stanley Small Cap Conference Archive for TARO
04/26/05		Q1 2005 Earnings Archive for TARO

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Daily Market Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs